Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. - Lindmark, F.; Zheng, S. L.; Wiklund, F.; Bälter, K. A.; Sun, J.; Chang, B.; Hedelin, M.; Clark, J.; Johansson, J.-E.; Meyers, D. A.; Adami, H.-O.; Isaacs, W.; et al. (British Journal of Cancer, 2005)